+高级检索
首页 > 过刊浏览>2020年第19卷第5期 >388-392. DOI:10.11915/j.issn.1671-5403.2020.05.092
PDF HTML阅读 XML下载 导出引用 引用提醒
免疫炎症干预——缺血性卒中治疗新曙光
作者:
作者单位:

(哈尔滨医科大学附属第二医院神经内科,哈尔滨 150081)


Intervention of immune and inflammatory responses in treatment of ischemic stroke:dawn of a new era
Author:
Affiliation:

(Department of Neurology, Second Affiliated Hospital, Harbin Medical University, Harbin 150086, China)

  • 摘要
    • | |
  • 访问统计
    • |
  • 参考文献 [27]
    • |
  • 相似文献 [20]
    • | | |
  • 文章评论

    【摘要】缺血性卒中因高复发和高致残性成为世界范围内影响健康的一个主要问题,受到越来越多的关注。近期研究显示免疫炎症在脑卒中的各个方面都发挥着重要作用。本文就炎症细胞和相关抗体与脑卒中相互作用的研究进展、以及阻止其进展的新靶点进行阐述,希望能为缺血性卒中提供更佳治疗手段。

    基金项目:

    【Abstract】Ischemic stroke has become a major worldwide health problem due to its high recurrence and high disability and is getting increasing attention. Recent studies have shown that immune inflammation plays an important role in all aspects of stroke. This article reviews the progress in the research about the interaction between stroke and inflammatory cells and related antibodies, and the new target to prevent the progression of stroke with a view of providing more efficacious treatment for ischemic stroke.

    参考文献
    [1] Herisson F, Frodermann V, Courties G, et al.Direct vascular channels connect skull bone marrow and the brain surface enabling myeloid cell migration[J].Nat Neurosci, 2018,21(9):1209-1217.DOI:10.1038/s41593-018-0213-2.
    [2] Herz J, Sabellek P, Lane TE, et al.Role of neutrophils in exacerbation of brain injury after focal cerebral ischemia in hyperlipidemic mice[J].Stroke, 2015,46(10):2916-2925.DOI:10.1161/STROKEAHA.115.010620.
    [3] American Academy of Neurology.Use of anti-ICAM-1 therapy in ischemic stroke:results of the Enlimomab Acute Stroke Trial[J].Neurology, 2001,57:1428-1434.
    [4] Cuartero MI, Ballesteros I, Moraga A, et al.N2 neutrophils, novel players in brain inflammation after stroke:modulation by the PPARγ agonist rosiglitazone[J].Stroke, 2013,44(12):3498-3508.DOI:10.1161/STROKEAHA.113.002470.
    [5] Cai W, Liu S, Hu M, et al.Functional dynamics of neutrophils after ischemic stroke[J].Transl Stroke Res, 2019.DOI:10.1007/s12975-019-00694-y.[Epub ahead of print].
    [6] Certo M, Endo Y, Ohta K, et al.Activation of RXR/PPARγ underlies neuroprotection by bexarotene in ischemic stroke[J].Pharmacol Res, 2015,102:298-307.DOI:10.1016/j.phrs.2015.10.009.
    [7] Hu X, Li P, Guo Y, et al.Microglia/macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia[J].Stroke, 2012,43(11):3063-3070.DOI:10.1161/STROKEAHA.112.659656.
    [8] Kim BJ, Kim MJ, Park JM, et al.Reduced neurogenesis after suppressed inflammation by minocycline in transient cerebral ischemia in rat[J].J Neurol Sci, 2009,279(1-2):70-75.DOI:10.1016/j.jns.2008.12.025.
    [9] Chu HX, Broughton BR, Kim HA, et al.Evidence that Ly6C(hi) monocytes are protective in acute ischemic stroke by promoting M2 macrophage polarization[J].Stroke, 2015,46(7):1929-1937.DOI:10.1161/STROKEAHA.115.009426.
    [10] Miró-Mur F, Pérez-de-Puig I, Ferrer-Ferrer M, et al.Immature monocytes recruited to the ischemic mouse brain differentiate into macrophages with features of alternative activation[J].Brain Behav Immun, 2016,53:18-33.DOI:10.1016/j.bbi.2015.08.010.
    [11] Jones KA, Maltby S, Plank MW, et al.Peripheral immune cells infiltrate into sites of secondary neurodegeneration after ischemic stroke[J].Brain Behav Immun, 2018,67:299-307.DOI:10.1016/j.bbi.2017.09.006.
    [12] Mracsko E, Liesz A, Stojanovic A, et al.Antigen dependently activated cluster of differentiation 8-positive T cells cause perforin-mediated neurotoxicity in experimental-stroke[J].J Neurosci, 2014,34(50):16784-16795.DOI:10.1523/JNEUROSCI.1867-14.2014.
    [13] Shrestha R, Millington O, Brewer J, et al.Lymphocyte-mediated neuroprotection in vitro models of excitotoxicity involves astrocytic activation and the inhibition of MAP kinase signalling pathways[J].Neuropharmacology, 2014,76(Pt A):184-193.DOI:10.1016/j.neuropharm.2013.06.025.
    [14] Perez-Alvarez MJ, Mario VG, Irene BC, et al.Role of mTORC1 controlling proteostasis after brain ischemia[J].Front Neurosci, 2018,12:60.DOI:10.3389/fnins.2018.00060.
    [15] Khoshnam SE, Winlow W, Farzaneh M, et al.Pathogenic mechanisms following ischemic stroke[J].Neurol Sci, 2017,38(7):1167-1186.DOI:10.1007/s10072-017-2938-1.
    [16] Youl KJ, Joohyun P, Young CJ, et al.Inflammation after ischemic stroke:the role of leukocytes and glial cells[J].Exp Neurobiol, 2016,25(5):241-251.DOI:10.5607/en.2016.25.5.241.
    [17] Xie L, Li W, Hersh J, et al.Experimental ischemic stroke induces long-term T cell activation in the brain[J].J Cereb Blood Flow Metab, 2019,39(11):2268-2276.DOI:10.1177/0271-678X-18792372.
    [18] Liddelow SA, Guttenplan KA, Clarke LE, et al.Neurotoxic reactive astrocytes are induced by activated microglia[J].Nature, 2017,541(7638):481-487.DOI:10.1038/nature21029.
    [19] Zhu P, Hata R, Ogasawara M, et al.Targeted disruption of organic cation transporter 3(Oct3) ameliorates ischemic brain damage through modulating histamine and regulatory T cells[J].J Cereb Blood Flow Metab, 2012,32(10):1897-1908.DOI:10.1038/jcbfm.2012.92.
    [20] Shrestha R, Millington O, Brewer J, et al.Lymphocyte-mediated neuroprotection in vitro models of excitotoxicity involves astrocytic activation and the inhibition of MAP kinase signalling pathways[J].Neuropharmacology, 2014,76:184-193.DOI:10.1016/j.neuropharm.2013.06.025.
    [21] Li M, Li Z, Yao Y, et al.Astrocyte-derived interleukin-15 exacerbates ischemic brain injury via propagation of cellular immunity[J].Proc Natl Acad Sci USA, 2017,114(3):E396-E405.DOI:10.1073/pnas.1612930114.
    [22] Bornstein NM, Aronovich B, Korczyn AD, et al.Antibodies to brain antigens following stroke[J].Neurology, 2001,56(4):529-530.DOI:10.1212/wnl.56.4.529.
    [23] Becker KJ, Kalil AJ, Tanzi P, et al.Autoimmune responses to brain following stroke are associated with worse outcome[J].Stroke, 2011,42:2763-2769.DOI:10.1161/STROKEAHA.111.619593.
    [24] Cho HJ, Kim SS, Sung SM, et al.Impact of thyroid autoantibodies on functional outcome in patients with acute ischemic stroke[J].J Stroke Cerebrovasc Dis, 2014,23(7):1915-1920.DOI:10.1016/j.jstrokecerebrovasdis.2014.02.008.
    [25] Carbone F, Satta N, Montecucco F, et al.Anti-ApoA-1 IgG serum levels predict worse post-stroke outcomes[J].Eur J Clin Invest, 2016,46(9):805-817.DOI:10.1111/eci.12664.
    [26] Hosseini H, Li Y, Kanellakis P, et al.Phosphatidylserine liposomes mimic apoptotic cells to attenuate atherosclerosis by expand-ing polyreactive IgM producing B1a lymphocytes[J].Cardiovasc Res, 2015,106(3):443-452.DOI:10.1093/cvr/cvv037.
    [27] Yoichi Y, Takaki H, Toshio M, et al.Elevation of autoantibody in patients with ischemic stroke[J].Neurol Med Chir (Tokyo), 2018,58(7):303-310.DOI:10.2176/nmc.ra.2018-0022.
    引证文献
    网友评论
    网友评论
    分享到微博
    发 布
引用本文

常晓凤,杨春晓.免疫炎症干预——缺血性卒中治疗新曙光[J].中华老年多器官疾病杂志,2020,19(5):388-392

复制
分享
文章指标
  • 点击次数:604
  • 下载次数: 834
  • HTML阅读次数: 0
  • 引用次数: 0
历史
  • 收稿日期:2019-06-26
  • 在线发布日期: 2020-06-02
文章二维码
您是第4191930 位访问者
主管单位：中国人民解放军总医院
主办单位：解放军总医院医学创新研究部、国家老年疾病临床医学研究中心（解放军总医院）、解放军总医院第六医学中心心血管病医学部
地址：北京市复兴路28号《中华老年多器官疾病杂志》编辑部
电话：010-66936756
中华老年多器官疾病杂志 ® 2025 版权所有 技术支持：北京勤云科技发展有限公司